Outcomes with General Anesthesia Compared to Conscious Sedation for Endovascular Treatment of Medium Vessel Occlusions: Results of an International Multicentric Study.

Anesthesia MeVO Outcomes research Reperfusion Stroke Thrombectomy

Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 24 02 2024
accepted: 14 04 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 30 4 2024
Statut: aheadofprint

Résumé

Optimal anesthetic strategy for the endovascular treatment of stroke is still under debate. Despite scarce data concerning anesthetic management for medium and distal vessel occlusions (MeVOs) some centers empirically support a general anesthesia (GA) strategy in these patients. We conducted an international retrospective study of MeVO cases. A propensity score matching algorithm was used to mitigate potential differences across patients undergoing GA and conscious sedation (CS). Comparisons in clinical and safety outcomes were performed between the two study groups GA and CS. The favourable outcome was defined as a modified Rankin Scale (mRS) 0-2 at 90 days. Safety outcomes were 90-days mortality and symptomatic intracranial hemorrhage (sICH). Predictors of a favourable outcome and sICH were evaluated with backward logistic regression. After propensity score matching 668 patients were included in the CS and 264 patients in the GA group. In the matched cohort, either strategy CS or GA resulted in similar rates of good functional outcomes (50.1% vs. 48.4%), and successful recanalization (89.4% vs. 90.2%). The GA group had higher rates of 90-day mortality (22.6% vs. 16.5%, p < 0.041) and sICH (4.2% vs. 0.9%, p = 0.001) compared to the CS group. Backward logistic regression did not identify GA vs CS as a predictor of good functional outcome (OR for GA vs CS = 0.95 (0.67-1.35)), but GA remained a significant predictor of sICH (OR = 5.32, 95% CI 1.92-14.72). Anaesthetic strategy in MeVOs does not influence favorable outcomes or final successful recanalization rates, however, GA may be associated with an increased risk of sICH and mortality.

Sections du résumé

BACKGROUND BACKGROUND
Optimal anesthetic strategy for the endovascular treatment of stroke is still under debate. Despite scarce data concerning anesthetic management for medium and distal vessel occlusions (MeVOs) some centers empirically support a general anesthesia (GA) strategy in these patients.
METHODS METHODS
We conducted an international retrospective study of MeVO cases. A propensity score matching algorithm was used to mitigate potential differences across patients undergoing GA and conscious sedation (CS). Comparisons in clinical and safety outcomes were performed between the two study groups GA and CS. The favourable outcome was defined as a modified Rankin Scale (mRS) 0-2 at 90 days. Safety outcomes were 90-days mortality and symptomatic intracranial hemorrhage (sICH). Predictors of a favourable outcome and sICH were evaluated with backward logistic regression.
RESULTS RESULTS
After propensity score matching 668 patients were included in the CS and 264 patients in the GA group. In the matched cohort, either strategy CS or GA resulted in similar rates of good functional outcomes (50.1% vs. 48.4%), and successful recanalization (89.4% vs. 90.2%). The GA group had higher rates of 90-day mortality (22.6% vs. 16.5%, p < 0.041) and sICH (4.2% vs. 0.9%, p = 0.001) compared to the CS group. Backward logistic regression did not identify GA vs CS as a predictor of good functional outcome (OR for GA vs CS = 0.95 (0.67-1.35)), but GA remained a significant predictor of sICH (OR = 5.32, 95% CI 1.92-14.72).
CONCLUSION CONCLUSIONS
Anaesthetic strategy in MeVOs does not influence favorable outcomes or final successful recanalization rates, however, GA may be associated with an increased risk of sICH and mortality.

Identifiants

pubmed: 38687365
doi: 10.1007/s00062-024-01415-1
pii: 10.1007/s00062-024-01415-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Campbell D, Butler E, Campbell RB, Ho J, Barber PA. General anesthesia compared with non-GA in endovascular thrombectomy for Ischemic stroke. Neurology. 2023;100(16):e1655. http://n.neurology.org/content/100/16/e1655.abstract .
doi: 10.1212/WNL.0000000000207066 pubmed: 36797071 pmcid: 10115505
Simonsen CZ, Yoo AJ, Sørensen LH, Juul N, Johnsen SP, Andersen G, et al. Effect of general anesthesia and conscious sedation during Endovascular therapy on infarct growth and clinical outcomes in acute Ischemic stroke: a randomized clinical trial. JAMA Neurol. 2018;75(4):470–7. https://doi.org/10.1001/jamaneurol.2017.4474 .
doi: 10.1001/jamaneurol.2017.4474 pubmed: 29340574 pmcid: 5885172
Löwhagen Hendén P, Rentzos A, Karlsson JE, Rosengren L, Leiram B, Sundeman H, et al. General anesthesia versus conscious sedation for endovascular treatment of acute Ischemic stroke. Stroke. 2017;48(6):1601–7. https://doi.org/10.1161/STROKEAHA.117.016554 .
doi: 10.1161/STROKEAHA.117.016554 pubmed: 28522637
Schönenberger S, Uhlmann L, Hacke W, Schieber S, Mundiyanapurath S, Purrucker JC, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular Thrombectomy: a randomized clinical trial. JAMA. 2016;316(19):1986–96. https://doi.org/10.1001/jama.2016.16623 .
doi: 10.1001/jama.2016.16623 pubmed: 27785516
Chabanne R, Geeraerts T, Begard M, Balança B, Rapido F, Degos V, et al. Outcomes after endovascular therapy with procedural sedation vs general anesthesia in patients with acute Ischemic stroke: the AMETIS randomized clinical trial. JAMA Neurol. 2023;80(5):474–83. https://doi.org/10.1001/jamaneurol.2023.0413 .
doi: 10.1001/jamaneurol.2023.0413 pubmed: 37010829 pmcid: 10071397
Maurice A, Eugène F, Ronzière T, Devys JM, Taylor G, Subileau A, et al. General anesthesia versus sedation, both with hemodynamic control, during Intraarterial treatment for stroke: the GASS randomized trial. Anesthesiology. 2022;136(4):567–76. https://doi.org/10.1097/ALN.0000000000004142 .
doi: 10.1097/ALN.0000000000004142 pubmed: 35226737
Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, et al. Effect of general anesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 2018;17(1):47–53. https://doi.org/10.1016/S1474-4422(17)30407-6 .
doi: 10.1016/S1474-4422(17)30407-6 pubmed: 29263006
Saver JL, Chapot R, Agid R, Hassan A, Jadhav AP, Liebeskind DS, et al. Thrombectomy for distal, medium vessel occlusions: a consensus statement on present knowledge and promising directions. Stroke. 2020; https://doi.org/10.1161/STROKEAHA.120.028956 .
doi: 10.1161/STROKEAHA.120.028956 pubmed: 33280549 pmcid: 7831886
Kappelhof M, Ospel JM, Cimflova P, Kashani N, Singh N, McDonough R, et al. Worldwide anaesthesia use during endovascular treatment for medium vessel occlusion stroke. Interv Neuroradiol. 2021;28(4):469–75. https://doi.org/10.1177/15910199211041487 .
doi: 10.1177/15910199211041487 pubmed: 34665059 pmcid: 9326870
Cappellari M, Pracucci G, Forlivesi S, Saia V, Nappini S, Nencini P, et al. General anesthesia versus conscious sedation and local anesthesia during thrombectomy for acute Ischemic stroke. Stroke. 2020;51(7):2036–44.
doi: 10.1161/STROKEAHA.120.028963 pubmed: 32517584
Meyer L, Stracke CP, Broocks G, Wallocha M, Elsharkawy M, Sporns PB, et al. Effect of anesthetic strategies on distal stroke thrombectomy in the anterior and posterior cerebral artery. J Neurointerv Surg. 2024; https://doi.org/10.1136/jnis-2023-020210 . https://jnis.bmj.com/content/early/2023/05/03/jnis-2023-020210 .
doi: 10.1136/jnis-2023-020210 pubmed: 38418227
Siegler JE, Shaikh H, Khalife J, Oak S, Zhang L, Abdalkader M, et al. Aspiration versus stent-retriever as first-line endovascular therapy technique for primary medium and distal Intracranial occlusions: a propensity-score matched multicenter analysis. Stroke. 2023; https://doi.org/10.1161/SVIN.123.000931 .
doi: 10.1161/SVIN.123.000931 pubmed: 37602387
Radu RA, Costalat V, Fahed R, Ghozy S, Siegler JE, Shaikh H, et al. First pass effect as an independent predictor of functional outcomes in medium vessel occlusions: An analysis of an international multicenter study. Eur Stroke J. 2023; https://doi.org/10.1177/23969873231208276 .
doi: 10.1177/23969873231208276 pubmed: 37885243 pmcid: 10916815
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245–51. https://doi.org/10.1016/S0140-6736(98)08020-9 .
doi: 10.1016/S0140-6736(98)08020-9 pubmed: 9788453
Schönenberger S, Hendén PL, Simonsen CZ, Uhlmann L, Klose C, Pfaff JAR, et al. Association of general anesthesia vs procedural sedation with functional outcome among patients with acute Ischemic stroke undergoing Thrombectomy: a systematic review and meta-analysis. JAMA. 2019;322(13):1283–93.
doi: 10.1001/jama.2019.11455 pubmed: 31573636 pmcid: 6777267
Terceño M, Bashir S, Cienfuegos J, Murillo A, Vera-Monge VA, Pardo L, et al. General anesthesia versus conscious sedation during endovascular treatment in posterior circulation large vessel occlusion: a systematic review and meta-analysis. Eur Stroke J. 2023;8(1):85–92. https://doi.org/10.1177/23969873221127738 .
doi: 10.1177/23969873221127738 pubmed: 37021193
Han H, Wang Y, Wang H, Sun H, Wang X, Gong J, et al. General anesthesia vs. local anesthesia during endovascular treatment for acute large vessel occlusion: a propensity score-matched analysis. Front Neurol. 2021;12:801024.
doi: 10.3389/fneur.2021.801024 pubmed: 35237222
Amini M, van Leeuwen N, Eijkenaar F, van de Graaf R, Samuels N, van Oostenbrugge R, et al. Estimation of treatment effects in observational stroke care data: comparison of statistical approaches. BMC Med Res Methodol. 2022;22(1):1–12. https://doi.org/10.1186/s12874-022-01590-0 .
doi: 10.1186/s12874-022-01590-0

Auteurs

Răzvan Alexandru Radu (RA)

Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France. raduarazvan@yahoo.com.
Department of Clinical Neurosciences, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. raduarazvan@yahoo.com.

Vincent Costalat (V)

Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.

Michele Romoli (M)

Neurology and Stroke Unit, Bufalini Hospital, AUSL Romagna, Cesena, Italy.

Basel Musmar (B)

Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Louisiana, LA, USA.

James E Siegler (JE)

Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowen University, Camden, NJ, USA.

Sherief Ghozy (S)

Departments of Neurological Surgery & Radiology, Mayo Clinic, Rochester, MN, USA.

Jane Khalife (J)

Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowen University, Camden, NJ, USA.

Hamza Salim (H)

Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Louisiana, LA, USA.

Hamza Shaikh (H)

Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowen University, Camden, NJ, USA.

Nimer Adeeb (N)

Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Louisiana, LA, USA.

Hugo H Cuellar-Saenz (HH)

Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Louisiana, LA, USA.

Ajith J Thomas (AJ)

Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowen University, Camden, NJ, USA.

Ramanathan Kadirvel (R)

Departments of Neurological Surgery & Radiology, Mayo Clinic, Rochester, MN, USA.

Mohamad Abdalkader (M)

Departments of Radiology & Neurology, Boston Medical Center, Boston, MA, USA.

Piers Klein (P)

Departments of Radiology & Neurology, Boston Medical Center, Boston, MA, USA.

Thanh N Nguyen (TN)

Departments of Radiology & Neurology, Boston Medical Center, Boston, MA, USA.

Jeremy J Heit (JJ)

Department of Interventional Neuroradiology, Stanford Medical Center, Palo Alto, CA, USA.

Robert W Regenhardt (RW)

Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.

Joshua D Bernstock (JD)

Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.

Aman B Patel (AB)

Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.

James D Rabinov (JD)

Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.

Christopher J Stapleton (CJ)

Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.

Nicole M Cancelliere (NM)

Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.

Thomas R Marotta (TR)

Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.

Vitor Mendes Pereira (V)

Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.

Kareem El Naamani (K)

Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.

Abdelaziz Amllay (A)

Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.

Stavropoula I Tjoumakaris (SI)

Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.

Pascal Jabbour (P)

Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.

Lukas Meyer (L)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jens Fiehler (J)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tobias D Faizy (TD)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Radiology, Interventional Neuroradiology Section, University Medical Center Münster, Munster, Germany.

Helena Guerreiro (H)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Anne Dusart (A)

Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.

Flavio Bellante (F)

Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.

Géraud Forestier (G)

University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.

Aymeric Rouchaud (A)

University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.

Charbel Mounayer (C)

University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.

Anna Luisa Kühn (AL)

Division of Neurointerventional Radiology, Department of Radiology, University of Massachusetts Medical Center, Worcester, MA, USA.

Ajit S Puri (AS)

Division of Neurointerventional Radiology, Department of Radiology, University of Massachusetts Medical Center, Worcester, MA, USA.

Christian Dyzmann (C)

Neuroradiology Department, Sana Kliniken, Lübeck GmbH, Lübeck, Germany.

Peter T Kan (PT)

Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX, USA.

Marco Colasurdo (M)

Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX, USA.
Department of Interventional Radiology, Oregon Health and Science University, 97239, Portland, OR, USA.

Gaultier Marnat (G)

Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.

Jérôme Berge (J)

Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.

Xavier Barreau (X)

Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.

Igor Sibon (I)

Neurology Department, Bordeaux University Hospital, Bordeaux, France.

Simona Nedelcu (S)

Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Nils Henninger (N)

Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Department of Psychiatry, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Takahiro Ota (T)

Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Shogo Dofuku (S)

Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Leonard L L Yeo (LLL)

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Benjamin Yq Tan (BY)

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Division of Neurology, Department of Medicine, National University Hospital, Singapore, Singapore.

Anil Gopinathan (A)

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Division of Interventional Radiology, National University Hospital, Singapore, Singapore.

Juan Carlos Martinez-Gutierrez (JC)

Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.

Sergio Salazar-Marioni (S)

Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.

Sunil Sheth (S)

Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.

Leonardo Renieri (L)

Interventistica Neurovascolare, Ospedale Careggi di Firenze, Florence, Italy.

Carolina Capirossi (C)

Interventistica Neurovascolare, Ospedale Careggi di Firenze, Florence, Italy.

Ashkan Mowla (A)

Division of Stroke and Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California (USC), North State St, Suite 3300, 1200, Los Angeles, CA, USA.

Lina M Chervak (LM)

Department of Neurology and Radiology, University of Cincinnati, Cincinnati, USA.

Achala Vagal (A)

Department of Neurology and Radiology, University of Cincinnati, Cincinnati, USA.

Priyank Khandelwal (P)

Department of Endovascular Neurosurgery and Neuroradiology NJMS, Newark, NJ, USA.

Arundhati Biswas (A)

Department of Neurosurgery, Westchester Medical Center at New York Medical College, Valhalla, NY, USA.

Frédéric Clarençon (F)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.
Division of Interventional Radiology, National University Hospital, Singapore, Singapore.

Mahmoud Elhorany (M)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.
Neurology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Division of Interventional Radiology, National University Hospital, Singapore, Singapore.

Kevin Premat (K)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.
Division of Interventional Radiology, National University Hospital, Singapore, Singapore.

Iacopo Valente (I)

UOSA Neuroradiologia Interventistica, Fondazione Policlinico Universitario A.Gemelli IRCCS Roma, Rome, Italy.

Alessandro Pedicelli (A)

UOSA Neuroradiologia Interventistica, Fondazione Policlinico Universitario A.Gemelli IRCCS Roma, Rome, Italy.

Andrea M Alexandre (AM)

UOSA Neuroradiologia Interventistica, Fondazione Policlinico Universitario A.Gemelli IRCCS Roma, Rome, Italy.

João Pedro Filipe (JP)

Department of Diagnostic and Interventional Neuroradiology, Centro Hospitalar Universitário do Porto, Porto, Portugal.

Ricardo Varela (R)

Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.

Miguel Quintero-Consuegra (M)

Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, USA.

Nestor R Gonzalez (NR)

Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, USA.

Markus A Ymd (MA)

Sektion Vaskuläre und Interventionelle Neuroradiologie, Universitätsklinikum Heidelberg, Heidelberg, Germany.

Jessica Jesser (J)

Sektion Vaskuläre und Interventionelle Neuroradiologie, Universitätsklinikum Heidelberg, Heidelberg, Germany.

Charlotte Weyland (C)

Sektion Vaskuläre und Interventionelle Neuroradiologie, Universitätsklinikum Heidelberg, Heidelberg, Germany.

Adrien Ter Schiphorst (A)

Department of Neurology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.

Vivek Yedavalli (V)

Department of Radiology, Division of Neuroradiology, Johns Hopkins Medical Center, Baltimore, MD, USA.

Pablo Harker (P)

Department of Neurology, University of Cincinnati Medical Center, Cincinnati, OH, USA.

Yasmin Aziz (Y)

Department of Neurology, University of Cincinnati Medical Center, Cincinnati, OH, USA.

Benjamin Gory (B)

Department of Interventional Neuroradiology, Nancy University Hospital, Nancy, France.
INSERM U1254, IADI, Université de Lorraine, 54511, Vandoeuvre-les-Nancy, France.

Christian Paul Stracke (C)

Department of Radiology, Interventional Neuroradiology Section, University Medical Center Münster, Munster, Germany.

Constantin Hecker (C)

Departments of Neurology & Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University Salzburg, Salzburg, Austria.

Monika Killer-Oberpfalzer (M)

Departments of Neurology & Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University Salzburg, Salzburg, Austria.

Christoph J Griessenauer (CJ)

Departments of Neurology & Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University Salzburg, Salzburg, Austria.

Cheng-Yang Hsieh (CY)

Neurology Department, Sin-Lau Hospital, Tainan, Taiwan, Province of China.

David S Liebeskind (DS)

UCLA Stroke Center and Department of Neurology Department, UCLA, Los Angeles, California, USA.

Illario Tancredi (I)

Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada.

Robert Fahed (R)

Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada.

Boris Lubicz (B)

Department of Diagnostic and Interventional Neuroradiology, Erasme University Hospital, Brussels, Belgium.

Muhammed Amir Essibayi (MA)

Department of Neurological Surgery and Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Amanda Baker (A)

Department of Neurological Surgery and Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

David Altschul (D)

Department of Neurological Surgery and Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Luca Scarcia (L)

Department of Neuroradiology, Henri Mondor Hospital, Creteil, France.

Erwah Kalsoum (E)

Department of Neuroradiology, Henri Mondor Hospital, Creteil, France.

Adam A Dmytriw (AA)

Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.

Adrien Guenego (A)

Department of Diagnostic and Interventional Neuroradiology, Erasme University Hospital, Brussels, Belgium.

Classifications MeSH